Icon Plc (ICLR) Financial Statements
Historical financial data — 5 statements covering FY2021–FY2025
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical tr...
Icon Plc's revenue increased 0.8% year over year, from $8.19B to $8.25B.
Net income decreased 70.6% over the same period, from $727.1M to $214.0M.
Over the 4-year period from FY2021 to FY2025, revenue grew by 51% in total.
Total debt remained relatively stable at $3.53B.
The debt-to-equity ratio stands at 0.38, indicating a moderate leverage profile.
Operating cash flow grew 3.1% to $1.11B.
Icon Plc maintains a moderate net profit margin of 2.6%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | Gross Profit | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2021 | $5.48B | $153.2M | $1.51B | $534.1M | $563.3M | $17.19B | $4.83B | $8.50B |
| FY2022 | $7.74B+41.2% | $505.3M | $2.22B | $866.1M | $1.16B | $16.86B | $3.94B | $9.21B |
| FY2023 | $8.05B+4.1% | $554.2M | $2.36B | $994.2M | $1.33B | $16.69B | $3.60B | $9.50B |
| FY2024 | $8.19B+1.7% | $727.1M | $2.37B | $1.04B | $1.08B | $16.33B | $3.56B | $9.25B |
| FY2025 | $8.25B+0.8% | $214.0M | $2.18B | $427.1M | $1.11B | $16.40B | $3.53B | $9.38B |
Balance Sheet Summary (Latest Period)
Icon Plc (ICLR) Financial Statements & Revenue History
Icon Plc (ICLR) is a US-listed stock operating in the Other sector trading at $163.90 with a market capitalization of $13. This page provides 5 historical financial statements for Icon Plc, including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, Icon Plc reported revenue of $8.3 billion, representing 0.8% year-over-year growth. The net profit margin of 2.6% suggests thin margins. The debt-to-equity ratio of 0.38 shows conservative leverage.
ICLR Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows Icon Plc's revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether ICLR is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track ICLR's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently Icon Plc converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of ICLR's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use ICLR Financial Data
Investors use Icon Plc's financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare ICLR's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how ICLR's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View ICLR's financial health score, earnings, and pre-market pricing.
Financial data is sourced from Icon Plc's SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.ICLR trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.